Disulfiram targeting lymphoid malignant cell lines via ROS-JNK activation as well as Nrf2 and NF-kappa B pathway inhibition
文献类型：期刊论文
| 作者 | Zha, Jie ; Chen, Feili ; Dong, Huijuan ; Shi, Pengcheng ; Yao, Yao ; Zhang, Yanyan ; Li, Rongwei ; Wang, Shiyun ; Li, Peng ; Wang, Weiguang ; Xu, Bing |
| 刊名 | JOURNAL OF TRANSLATIONAL MEDICINE
 |
| 出版日期 | 2014 |
| 卷号 | 12 |
| ISSN号 | 1479-5876 |
| 学科主题 | Research & Experimental Medicine |
| 语种 | 英语 |
| 公开日期 | 2016-12-16 |
| 源URL | [http://ir.gibh.ac.cn/handle/344009/325]  |
| 专题 | 广州生物医药与健康研究院_华南干细胞与再生医学研究所_华南干细胞与再生医学研究所_期刊论文 |
| 推荐引用方式 GB/T 7714 | Zha, Jie,Chen, Feili,Dong, Huijuan,et al. Disulfiram targeting lymphoid malignant cell lines via ROS-JNK activation as well as Nrf2 and NF-kappa B pathway inhibition[J]. JOURNAL OF TRANSLATIONAL MEDICINE,2014,12. |
| APA | Zha, Jie.,Chen, Feili.,Dong, Huijuan.,Shi, Pengcheng.,Yao, Yao.,...&Xu, Bing.(2014).Disulfiram targeting lymphoid malignant cell lines via ROS-JNK activation as well as Nrf2 and NF-kappa B pathway inhibition.JOURNAL OF TRANSLATIONAL MEDICINE,12. |
| MLA | Zha, Jie,et al."Disulfiram targeting lymphoid malignant cell lines via ROS-JNK activation as well as Nrf2 and NF-kappa B pathway inhibition".JOURNAL OF TRANSLATIONAL MEDICINE 12(2014). |
入库方式： OAI收割
来源：广州生物医药与健康研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。